Clinical Trial Update: The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings. [NA]

View source ↗

Summary

A clinical trial evaluating six weeks of pre-operative administration of the microbiome modulator WellBiome versus placebo in patients with cardiovascular disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• WellBiome

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Cardiovascular Diseases (CVD), Cardiovascular Surgery | NA | Status: NOT_YET_RECRUITING